Pasithea Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.73

-0.04 (-4.82%)

As of Feb 8, 2:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +3,613.1% upside

Low Target $19.73

Average Target $26.92

High Target $29.00

Current Price $0.73

Current
$0.73

Target
$26.92

$19.73 $26.92 avg $29.00

Scenario Analysis

Bear Case

$19.73

2,621.4%

Low target

Base Case

$26.92

+3,613.1%

Avg target

Bull Case

$29.00

+3,900.0%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$23.54

-96.9% from high

52-Week Low

$13.49

+-94.6% from low

Target vs 52W High

$26.92

+14.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%